Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Bacterial adhesion to gastric mucosa" refers to the process by which bacteria—most notably Helicobacter pylori—attach themselves to the epithelial lining of the human stomach using specialized surface proteins called adhesins. This interaction is essential for successful colonization and persistence within the harsh acidic environment. Key H. pylori adhesins include BabA (binding Lewis b antigens), SabA (binding sialylated glycans), HopQ (binding CEACAM family receptors), and HpaA; these facilitate tight binding between bacterium and host cell surfaces. The adhesion process enables bacteria not only to resist being flushed out by mucus turnover but also allows them access to nutrients and positions them optimally for delivering virulence factors such as CagA into host cells via secretion systems—a critical step in triggering inflammation, tissue damage, gastritis, peptic ulcers, and increasing risk for gastric cancer development. Because this is a biological process rather than a discrete molecular target like an enzyme or receptor protein—and involves multiple interacting molecules on both pathogen and host sides—it is not considered a canonical therapeutic target itself but rather describes an important pathogenic mechanism that can be targeted indirectly through drugs that block key adhesive interactions. "Bacterial adhesion to gastric mucosa" is not a single molecule or receptor but instead describes a complex biological event involving several distinct molecular targets on both bacterial (e.g., BabA/SabA/HopQ/HpaA) and human (e.g., Lewis antigens/CEACAMs/glycan structures) sides; thus it should not be treated as one canonical drug target entity.
Inhibition or disruption of bacterial adhesin-host receptor interactions to prevent colonization and subsequent pathogenesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial adhesion to gastric mucosa.